Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

Author： Burger R.A. DiSaia P.J. Roberts J.A. O'Rourke M. Gershenson D.M. Homesley H.D. Lichtman S.M. Barnes W. Moore D.H. Monk B.J.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.72, Iss.2, 1999-02, pp. : 148-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of capecitabine (Xeloda^®) in recurrent ovarian cancer

By Miller Brigitte

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 29-30

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer

By Hensley Martee

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 51-52

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C. Vermorken J.B. Mickiewicz E. Chevalier B. Alvarez A. Mendiola C. Pawinski A. Lentz M.A. Pecorelli S.

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

By Bolis G. Scarfone G. Sciatta C. Polverino G.P. Rosa C. Guarnerio P. Parazzini F.

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 477-480

Elsevier

Access to resources Recommend Favorite

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

By Esteban E.

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 127-133

Springer Publishing Company

Access to resources Recommend Favorite